Hinge Health, INC 8-K filings

Hinge Health announced record Q2 2026 results with 53% revenue growth to $213 million and tripling free cash flow, alongside a definitive agreement to acquire Cylinder Health for $105 million to expand into gastrointestinal care.

Hinge Health announced an increase in its revenue and operating margin guidance for Q2 and full year 2026, coinciding with its inaugural Investor Day event.

Hinge Health, Inc. successfully concluded its 2026 Annual Meeting, confirming the election of directors and the appointment of its independent auditor.

Hinge Health announced record first quarter 2026 financial results with 47% year-over-year revenue growth and raised its full-year revenue outlook.

Hinge Health, Inc. announced the immediate appointment of Tyler Sloat to its Board of Directors, where he will chair the Compensation Committee and serve on the Audit Committee.

Hinge Health announced record financial results for the fourth quarter and full year 2025, driven by strong commercial momentum and expanding margins.

Hinge Health's Board of Directors authorized a $250 million share repurchase program, signaling confidence in its financial strength and commitment to shareholder returns.

Hinge Health reported strong third-quarter 2025 financial results, with revenue increasing 53% year-over-year and record free cash flow, driven by growth in clients and members.

Hinge Health announces the early release of approximately 1.66 million Class A common shares from lock-up agreements for certain employees and service providers.

Hinge Health, Inc. announced strong second quarter 2025 financial results, driven by 55% year-over-year revenue growth and a significant shift to non-GAAP operating profitability.

Hinge Health, Inc. announced the successful completion of its initial public offering, raising over $272 million in gross proceeds for the company, alongside the adoption of a new corporate governance structure featuring a dual-class stock system.